Contribution of epidermal growth factor (EGF) in the treatment of cutaneous leishmaniasis caused by Leishmania major in BALB/c mice
PLOS Neglected Tropical Diseases · 2025
DOI: 10.1371/journal.pntd.0012765 ↗Kurz gefasst
Fachartikel in der Zeitschrift PLOS Neglected Tropical Diseases, 2025. Verfasst von Mohammad Saberi und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Parasitology and Mycology, School of Public Health, Tehran University of Medical Sciences, Tehran, Iran. Hauptthemen laut MEDLINE: Leishmaniasis, Cutaneous, Epidermal Growth Factor, Leishmania major, Antiprotozoal Agents. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 51 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Tehran University of Medical Sciences and Health Services.
Abstract (Originalsprache)
Cutaneous leishmaniasis (CL) is a tropical disease that can cause chronic lesions and leave life-long scars, leading to social stigmatization and psychological disorders. Using growth factors and immunomodulatory agents that could accelerate wound healing and reduce the scar is highly demanded. Epidermal growth factor (EGF) plays an essential role in wound healing. It stimulates the proliferation of keratocytes and fibroblasts, and promotes re-epithelialization. Here, the effect of EGF in combination with Glucantime and nano-liposomal Amphotericin B (SinaAmpholeish) on the healing process of CL in BALB/c mice was investigated. Seventy-two mice were infected with Leishmania major parasites and randomly divided into eight treatment groups after the appearance of the lesion. The treatment was continued for five weeks, and lesion sizes were measured weekly. Parasite load was determined in the skin biopsies using qPCR. We found that subcutaneous injection of EGF at 4.5 μg/kg, combined with each of the two antileishmanial drugs, significantly reduced the wound size and parasite load; however, EGF at 1.5 μg/kg failed to be effective. Besides, the wound size and parasite loads were significantly lower in the SinaAmfoleish groups compared to the Glucantime groups. Among the treatment groups, EGF 4.5 μg/kg combined with SinaAmpholeish exhibited the most significant reduction in wound size and parasitic load. Our results suggest that EGF can potentiate the wound healing effect of antileishmanial drugs. Further studies are warranted to explore the beneficial effects of combining EGF with antileishmanial drugs in patients with cutaneous leishmaniasis in order to accelerate wound healing and reduce the scar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Medical Parasitology and Mycology, School of Public Health, Tehran University of Medical Sciences, Tehran, Iran.
- Department of Parasitology, Pasteur Institute of Iran, Tehran, Iran.
- Department of Biochemistry, Pasteur Institute of Iran, Tehran, Iran.
- Department of Parasitology and Mycology, School of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran.
- Department of Parasitology and Mycology, School of Medicine, Jiroft University of Medical Sciences, Jiroft, Iran.
- Center for Research of Endemic Parasites of Iran, Tehran University of Medical Sciences, Tehran, Iran.
ORCID-Profile: Mehdi Mohebali
Förderung
- Tehran University of Medical Sciences and Health Services
Zitieren
APA
Saberi, M., Latifi, A., Golkar, M., Fard-Esfahani, P., Mohtasebi, S., Teimouri, A., Abbaszadeh Afshar, M. J., Kazemirad, E., & Mohebali, M. (2025). Contribution of epidermal growth factor (EGF) in the treatment of cutaneous leishmaniasis caused by Leishmania major in BALB/c mice. PLOS Neglected Tropical Diseases. https://doi.org/10.1371/journal.pntd.0012765
Vancouver
Saberi M, Latifi A, Golkar M, Fard-Esfahani P, Mohtasebi S, Teimouri A, et al. Contribution of epidermal growth factor (EGF) in the treatment of cutaneous leishmaniasis caused by Leishmania major in BALB/c mice. PLOS Neglected Tropical Diseases. 2025. doi:10.1371/journal.pntd.0012765
BibTeX
@article{Saberi2025,
author = {Saberi, Mohammad and Latifi, Alireza and Golkar, Majid and Fard-Esfahani, Pezhman and Mohtasebi, Sina and Teimouri, Aref and Abbaszadeh Afshar, Mohammad Javad and Kazemirad, Elham and Mohebali, Mehdi},
title = {Contribution of epidermal growth factor (EGF) in the treatment of cutaneous leishmaniasis caused by Leishmania major in BALB/c mice},
journal = {PLOS Neglected Tropical Diseases},
year = {2025},
doi = {10.1371/journal.pntd.0012765}
}
EUVIMED